Daniel Hornburg, PhD in

Daniel Hornburg, PhD

Login to view DISC.
Vice President Biomarkers & Precision Medicine (global) at Bruker
📍 San Francisco, California, United States

Daniel Hornburg is the Vice President of Biomarkers & Precision Medicine at Bruker, leveraging his extensive background in multi-omics and mass spectrometry. An alumnus of the Max Planck Society and Stanford University, he has a proven track record of driving technology advancements in fast-paced startups, including pivotal contributions to Seers successful IPO.

Fueled by a deep curiosity for understanding how things work, Daniel has had a lifelong interest in science and space. He believes science encourages a collaborative, "need-to-learn" perspective and appreciates gaining knowledge from people with different viewpoints and backgrounds. He approaches challenges with optimism and a desire for discovery.

He received the prestigious HUPO 2022 Proteomics Science and Technology Award for his interdisciplinary research that enabled groundbreaking proteomics technology.

Read the full overview →
Experience
14 Years
Current Role
Vice President Biomarkers & Precision Medicine (global)
Job Level
Senior
Location
San Francisco, California, United States
Personality Overview

How Daniel shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Daniel cares about

Precision Medicine
His current role is focused on translating proteomics and biomarker discoveries into tangible patient impact, such as developing non-invasive cancer tests.
Proteomics Technology
Leads the global strategy for next-generation proteomics tech at Bruker, including innovations in LC-MS, spatial proteomics, and single-cell analysis.
+5 more topics Login to view topics
Career

Work history

11-2023
Vice President Biomarkers & Precision Medicine (global)
Bruker
5-2022 - 11-2023
Vice President Proteomics
Seer
9-2021 - 5-2022
Senior Director Discovery
Seer
9-2020 - 9-2021
Principal Scientist
Seer
8-2019 - 11-2023
Scientific Consultant: Multi-omics bioinformatics
Stanford University School of Medicine
In the press

Media appearances

Bruker Announces Advancements in Immunopeptidomics, de novo PTM Analysis and Proteoform Profiling. Featured in Newswire Today
See now
Education
Postdoctoral Scientist
Stanford University
Dr. rer. nat. (PhD)
Max Planck Society
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Bruker Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Daniel. Free, 10 seconds.